Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
123I-EGF uptake in tumours pre...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
123I-EGF uptake in tumours predicts long-term farnesyltransferase therapy outcome in athymic mice
Bibliographic Details
Main Authors:
Cornelissen, B
,
Kersemans, V
,
Van de Wiele, C
,
Dierckx, R
,
Bonnano, E
,
Signore, A
,
Slegers, G
Format:
Conference item
Published:
2004
Holdings
Description
Similar Items
Staff View
Similar Items
Detection of various tumour types in athymic mice with [123I]-2-Iodo-L-Phenylalanine and planar gamma camera acquisition
by: Kersemans, V, et al.
Published: (2004)
123I-EGF internalisation in tumour cells in vitro is inhibited by farnesyltransferase inhibitor therapy: possible target for early therapy response prediction
by: Cornelissen, B, et al.
Published: (2004)
In vivo evaluation of [I-123]-2-Iodo-D-Phenylalanine in tumour inoculated athymic mice by means of SPECT as a potential diagnostic and radionuclide therapy tool.
by: Kersemans, V, et al.
Published: (2004)
In vivo characterization of [123I]-2-Iodo-L-Phenylalanine in growing R1M rabdomyosarcoma bearing athymic mice as a potential tumour tracer for SPECT
by: Kersemans, V, et al.
Published: (2004)
In vivo apoptosis detection with radioiodinated Annexin V in LoVo tumour-bearing mice following Tipifarnib (Zarnestra, R115777) farnesyltransferase inhibitor therapy.
by: Cornelissen, B, et al.
Published: (2005)